Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CMA launches market study into supply of infant formula

(Sharecast News) - Watchdog the Competition and Markets Authority has launched a market study into the supply of infant formula in the UK, after first looking into the market back in November 2023. The CMA said on Tuesday that it intends to conduct its market study "as swiftly as possible" and intends to publish its final report in September.

The market study will look to gather additional evidence on consumer behaviour, the drivers of choice, and the information and advice available to consumers to support their decisions, as well as the role of the regulatory framework and its enforcement in influencing market outcomes and the supply-side features of the market.

Following the study, the CMA will consider whether there are problems in the market and, if so, what actions could or should be taken to address these - potentially including making recommendations to Westminster.

The CMA's move follows its Autumn 2023 report into price inflation and competition in the groceries sector, which found that the average price of infant formula had risen by 25% over the previous two years and that families could make "significant savings" of more than £500 over the first year of a baby's life, through buying cheaper infant formula options.

CMA chief executive Sarah Cardell said: "Whilst it's a positive sign that prices of some products have fallen since our update last November, the cost of infant milk remains at historically high levels. We're concerned that parents don't always have the right information to make informed choices and that suppliers may not have strong incentives to offer infant formula at competitive prices.

"We are determined to ensure this market is working well for the many new parents who depend on infant formula and it's essential that any changes we propose are based on evidence and a strong understanding of the market. That's why we've now decided to take forward our work on infant formula as a market study, using our formal legal powers."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Goldman Sachs to scrap bonus cap for UK dealmakers
(Sharecast News) - Goldman Sachs will remove a cap on bonuses for its London-based staff, according to Sky News, with the firm now set to resume making multi-million-pound payouts to its top-performing traders and dealmakers.
Gazprom swings to $6.9bn loss as Europe sales plunge
(Sharecast News) - Russia's natural gas heavyweight Gazprom swung to huge loss in 2023 after sales to Europe dropped due to Western sanctions on Moscow.
London cabbies launch £250m legal action against Uber
(Sharecast News) - Uber Technologies is facing legal action on behalf of more than 10,500 London black cab drivers, it was confirmed on Thursday.
Peloton announces CEO departure; to cut 15% of workforce
(Sharecast News) - Peloton announced the departure of its chief executive on Thursday, alongside plans to cut around 15% of its workforce amid a restructuring programme aimed at reducing annual expenses by more than $200m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.